| # | Drug | Count |
|---|---|---|
| 0 | MAGNESIUM | 42 |
| 1 | ACETAMINOPHEN | 41 |
| 2 | OMEPRAZOLE MAGNESIUM | 41 |
| 3 | LENALIDOMIDE | 37 |
| 4 | ERGOCALCIFEROL | 31 |
| 5 | OMEPRAZOLE | 30 |
| 6 | CISPLATIN | 28 |
| 7 | METOPROLOL TARTRATE | 28 |
| 8 | AMLODIPINE | 27 |
| 9 | FUROSEMIDE | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IODINE TINCTURE | 1 | 0.0556 |
| 1 | CHLORINE | 1 | 0.0159 |
| 2 | FACTOR XIII CONCENTRATE (HUMAN) | 1 | 0.0110 |
| 3 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 1 | 0.0102 |
| 4 | BENZYL ALCOHOL | 1 | 0.0095 |
| 5 | MANGANESE CHLORIDE | 1 | 0.0036 |
| 6 | CLEVIDIPINE | 1 | 0.0027 |
| 7 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 8 | AMINOCAPROIC ACID | 2 | 0.0025 |
| 9 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 65 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 2 | Thalidomide Analog [EPC] | 43 |
| 3 | Platinum-based Drug [EPC] | 41 |
| 4 | Proton Pump Inhibitor [EPC] | 41 |
| 5 | Kinase Inhibitor [EPC] | 39 |
| 6 | Benzodiazepine [EPC] | 36 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 33 |
| 8 | Loop Diuretic [EPC] | 31 |
| 9 | Provitamin D2 Compound [EPC] | 31 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 20 | 0.0015 |
| 1 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 2 | Provitamin D2 Compound [EPC] | 31 | 0.0010 |
| 3 | Actinomycin [EPC] | 2 | 0.0009 |
| 4 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 2 | 0.0008 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 7 | 0.0008 |
| 6 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 8 | Progestin Antagonist [EPC] | 3 | 0.0006 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 26 | 0.0005 |